Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Virchow's node (disorder)
|
disease |
|
Sign or Symptom
|
30
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Disorder of skeletal system
|
group |
Musculoskeletal Diseases
|
Disease or Syndrome
|
25
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma, Lewis Lung
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
188
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Medullary carcinoma of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
330
|
71
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Basophilic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
32
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult type dermatomyositis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
218
|
31
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Squamous cell carcinoma of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2053
|
329
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyaline body
|
disease |
|
Anatomical Abnormality
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adenocarcinoma of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
406
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyperhomocysteinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
246
|
45
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Decreased drug resistance
|
phenotype |
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1597
|
326
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
593
|
24
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mixed anxiety and depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
146
|
13
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Lip and Oral Cavity Carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
734
|
172
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.010 |
None |
< 0.001 |
1 |
|
2005 |
2005 |
Uterine Fibroids
|
group |
Neoplasms
|
Neoplastic Process
|
569
|
154
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |